Linked Data API

Show Search Form

Search Results

100721
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department of Health more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Osteoporosis more like this
star this property house id 1 more like this
star this property legislature
25259
unstar this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, how much from the publich purse has been spent on research into osteoporosis in each of the last five years. more like this
star this property tabling member constituency Leicester West more like this
star this property tabling member printed
Liz Kendall more like this
unstar this property uin 211732 more like this
star this property answer
answer
unstar this property is ministerial correction true more like this
star this property date of answer less than 2014-10-29more like thismore than 2014-10-29
unstar this property answer text <p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td> </td><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td colspan="6"><p>Asthma</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p><del class="ministerial">22.2 </del><ins class="ministerial">6.6</ins></p></td><td><p><del class="ministerial">17.5 </del><ins class="ministerial">5.3</ins></p></td><td><p><del class="ministerial">17.2</del><ins class="ministerial"> 4.5</ins></p></td><td><p><del class="ministerial">19.4</del><ins class="ministerial"> 3.6</ins></p></td><td><p><del class="ministerial">18.8</del><ins class="ministerial"> 5.4</ins></p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.3</p></td><td><p>1.5</p></td><td><p>0.8</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>2.6</p></td><td><p>3.4</p></td><td><p>2.4</p></td><td><p>3.4</p></td><td><p>3.8</p></td></tr><tr><td><p>Total</p></td><td><p><del class="ministerial">24.8</del><ins class="ministerial"> 9.2</ins></p></td><td><p><del class="ministerial">21.0</del><ins class="ministerial"> 8.8</ins></p></td><td><p><del class="ministerial">19.9</del><ins class="ministerial"> 7.2</ins></p></td><td><p><del class="ministerial">24.3 </del><ins class="ministerial">8.5</ins></p></td><td><p><del class="ministerial">23.4</del> <ins class="ministerial">10.0</ins></p></td></tr><tr><td colspan="6"><p>Motor Neurone Research</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>7.0</p></td><td><p>7.5</p></td><td><p>4.2</p></td><td><p>4.1</p></td><td><p>3.6</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr><tr><td><p>Total</p></td><td><p>7.3</p></td><td><p>7.8</p></td><td><p>5.0</p></td><td><p>5.5</p></td><td><p>5.1</p></td></tr><tr><td colspan="6"><p>Osteoporosis</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>6.2</p></td><td><p>5.4</p></td><td><p>5.1</p></td><td><p>4.6</p></td><td><p>5.9</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.3</p></td><td><p>0.7</p></td><td><p>0.8</p></td><td><p>1.3</p></td><td><p>1.8</p></td></tr><tr><td><p>Total</p></td><td><p>6.5</p></td><td><p>6.1</p></td><td><p>6.0</p></td><td><p>6.3</p></td><td><p>8.7</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.</p><p> </p><p> </p><p> </p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.</p><p> </p><p> </p><p> </p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.</p><p> </p>
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2014-10-29T17:12:28.3318918Zmore like thismore than 2014-10-29T17:12:28.3318918Z
star this property question first ministerially corrected
less than 2014-11-13T10:22:56.0372213Zmore like thismore than 2014-11-13T10:22:56.0372213Z
star this property answering member
4020
star this property label Biography information for George Freeman more like this
star this property previous answer version
25123
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property answering member
4020
star this property label Biography information for George Freeman more like this
star this property tabling member
4026
unstar this property label Biography information for Liz Kendall more like this
100723
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department of Health more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Motor Neurone Disease: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
unstar this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, how much from the public purse has been spent on the development of new drugs to prevent or treat symptoms of motore neurone disease in each of the last five years. more like this
star this property tabling member constituency Leicester West more like this
star this property tabling member printed
Liz Kendall more like this
unstar this property uin 211734 more like this
star this property answer
answer
unstar this property is ministerial correction true more like this
star this property date of answer less than 2014-10-29more like thismore than 2014-10-29
unstar this property answer text <p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td> </td><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td colspan="6"><p>Asthma</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p><del class="ministerial">22.2 </del><ins class="ministerial">6.6</ins></p></td><td><p><del class="ministerial">17.5 </del><ins class="ministerial">5.3</ins></p></td><td><p><del class="ministerial">17.2</del><ins class="ministerial"> 4.5</ins></p></td><td><p><del class="ministerial">19.4</del><ins class="ministerial"> 3.6</ins></p></td><td><p><del class="ministerial">18.8</del><ins class="ministerial"> 5.4</ins></p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.3</p></td><td><p>1.5</p></td><td><p>0.8</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>2.6</p></td><td><p>3.4</p></td><td><p>2.4</p></td><td><p>3.4</p></td><td><p>3.8</p></td></tr><tr><td><p>Total</p></td><td><p><del class="ministerial">24.8</del><ins class="ministerial"> 9.2</ins></p></td><td><p><del class="ministerial">21.0</del><ins class="ministerial"> 8.8</ins></p></td><td><p><del class="ministerial">19.9</del><ins class="ministerial"> 7.2</ins></p></td><td><p><del class="ministerial">24.3 </del><ins class="ministerial">8.5</ins></p></td><td><p><del class="ministerial">23.4</del> <ins class="ministerial">10.0</ins></p></td></tr><tr><td colspan="6"><p>Motor Neurone Research</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>7.0</p></td><td><p>7.5</p></td><td><p>4.2</p></td><td><p>4.1</p></td><td><p>3.6</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr><tr><td><p>Total</p></td><td><p>7.3</p></td><td><p>7.8</p></td><td><p>5.0</p></td><td><p>5.5</p></td><td><p>5.1</p></td></tr><tr><td colspan="6"><p>Osteoporosis</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>6.2</p></td><td><p>5.4</p></td><td><p>5.1</p></td><td><p>4.6</p></td><td><p>5.9</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.3</p></td><td><p>0.7</p></td><td><p>0.8</p></td><td><p>1.3</p></td><td><p>1.8</p></td></tr><tr><td><p>Total</p></td><td><p>6.5</p></td><td><p>6.1</p></td><td><p>6.0</p></td><td><p>6.3</p></td><td><p>8.7</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.</p><p> </p><p> </p><p> </p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.</p><p> </p><p> </p><p> </p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.</p><p> </p>
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2014-10-29T17:12:28.3318918Zmore like thismore than 2014-10-29T17:12:28.3318918Z
star this property question first ministerially corrected
less than 2014-11-13T10:22:56.0372213Zmore like thismore than 2014-11-13T10:22:56.0372213Z
star this property answering member
4020
star this property label Biography information for George Freeman more like this
star this property previous answer version
25123
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property answering member
4020
star this property label Biography information for George Freeman more like this
star this property tabling member
4026
unstar this property label Biography information for Liz Kendall more like this
100728
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department of Health more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Motor Neurone Disease more like this
star this property house id 1 more like this
star this property legislature
25259
unstar this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, how much from the public purse has been spent on research into motor neurone disease in each of the last five years. more like this
star this property tabling member constituency Leicester West more like this
star this property tabling member printed
Liz Kendall more like this
unstar this property uin 211730 more like this
star this property answer
answer
unstar this property is ministerial correction true more like this
star this property date of answer less than 2014-10-29more like thismore than 2014-10-29
unstar this property answer text <p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td> </td><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td colspan="6"><p>Asthma</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p><del class="ministerial">22.2 </del><ins class="ministerial">6.6</ins></p></td><td><p><del class="ministerial">17.5 </del><ins class="ministerial">5.3</ins></p></td><td><p><del class="ministerial">17.2</del><ins class="ministerial"> 4.5</ins></p></td><td><p><del class="ministerial">19.4</del><ins class="ministerial"> 3.6</ins></p></td><td><p><del class="ministerial">18.8</del><ins class="ministerial"> 5.4</ins></p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.3</p></td><td><p>1.5</p></td><td><p>0.8</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>2.6</p></td><td><p>3.4</p></td><td><p>2.4</p></td><td><p>3.4</p></td><td><p>3.8</p></td></tr><tr><td><p>Total</p></td><td><p><del class="ministerial">24.8</del><ins class="ministerial"> 9.2</ins></p></td><td><p><del class="ministerial">21.0</del><ins class="ministerial"> 8.8</ins></p></td><td><p><del class="ministerial">19.9</del><ins class="ministerial"> 7.2</ins></p></td><td><p><del class="ministerial">24.3 </del><ins class="ministerial">8.5</ins></p></td><td><p><del class="ministerial">23.4</del> <ins class="ministerial">10.0</ins></p></td></tr><tr><td colspan="6"><p>Motor Neurone Research</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>7.0</p></td><td><p>7.5</p></td><td><p>4.2</p></td><td><p>4.1</p></td><td><p>3.6</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr><tr><td><p>Total</p></td><td><p>7.3</p></td><td><p>7.8</p></td><td><p>5.0</p></td><td><p>5.5</p></td><td><p>5.1</p></td></tr><tr><td colspan="6"><p>Osteoporosis</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>6.2</p></td><td><p>5.4</p></td><td><p>5.1</p></td><td><p>4.6</p></td><td><p>5.9</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.3</p></td><td><p>0.7</p></td><td><p>0.8</p></td><td><p>1.3</p></td><td><p>1.8</p></td></tr><tr><td><p>Total</p></td><td><p>6.5</p></td><td><p>6.1</p></td><td><p>6.0</p></td><td><p>6.3</p></td><td><p>8.7</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.</p><p> </p><p> </p><p> </p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.</p><p> </p><p> </p><p> </p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.</p><p> </p>
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2014-10-29T17:12:28.3318918Zmore like thismore than 2014-10-29T17:12:28.3318918Z
star this property question first ministerially corrected
less than 2014-11-13T10:22:56.0372213Zmore like thismore than 2014-11-13T10:22:56.0372213Z
star this property answering member
4020
star this property label Biography information for George Freeman more like this
star this property previous answer version
25123
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property answering member
4020
star this property label Biography information for George Freeman more like this
star this property tabling member
4026
unstar this property label Biography information for Liz Kendall more like this
100730
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department of Health more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Osteoporosis: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
unstar this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, how much from the public purse has been spent on the development of new drugs to treat symptoms of osteoporosis in each of the last five years. more like this
star this property tabling member constituency Leicester West more like this
star this property tabling member printed
Liz Kendall more like this
unstar this property uin 211735 more like this
star this property answer
answer
unstar this property is ministerial correction true more like this
star this property date of answer less than 2014-10-29more like thismore than 2014-10-29
unstar this property answer text <p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td> </td><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td colspan="6"><p>Asthma</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p><del class="ministerial">22.2 </del><ins class="ministerial">6.6</ins></p></td><td><p><del class="ministerial">17.5 </del><ins class="ministerial">5.3</ins></p></td><td><p><del class="ministerial">17.2</del><ins class="ministerial"> 4.5</ins></p></td><td><p><del class="ministerial">19.4</del><ins class="ministerial"> 3.6</ins></p></td><td><p><del class="ministerial">18.8</del><ins class="ministerial"> 5.4</ins></p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.3</p></td><td><p>1.5</p></td><td><p>0.8</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>2.6</p></td><td><p>3.4</p></td><td><p>2.4</p></td><td><p>3.4</p></td><td><p>3.8</p></td></tr><tr><td><p>Total</p></td><td><p><del class="ministerial">24.8</del><ins class="ministerial"> 9.2</ins></p></td><td><p><del class="ministerial">21.0</del><ins class="ministerial"> 8.8</ins></p></td><td><p><del class="ministerial">19.9</del><ins class="ministerial"> 7.2</ins></p></td><td><p><del class="ministerial">24.3 </del><ins class="ministerial">8.5</ins></p></td><td><p><del class="ministerial">23.4</del> <ins class="ministerial">10.0</ins></p></td></tr><tr><td colspan="6"><p>Motor Neurone Research</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>7.0</p></td><td><p>7.5</p></td><td><p>4.2</p></td><td><p>4.1</p></td><td><p>3.6</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr><tr><td><p>Total</p></td><td><p>7.3</p></td><td><p>7.8</p></td><td><p>5.0</p></td><td><p>5.5</p></td><td><p>5.1</p></td></tr><tr><td colspan="6"><p>Osteoporosis</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>6.2</p></td><td><p>5.4</p></td><td><p>5.1</p></td><td><p>4.6</p></td><td><p>5.9</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.3</p></td><td><p>0.7</p></td><td><p>0.8</p></td><td><p>1.3</p></td><td><p>1.8</p></td></tr><tr><td><p>Total</p></td><td><p>6.5</p></td><td><p>6.1</p></td><td><p>6.0</p></td><td><p>6.3</p></td><td><p>8.7</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.</p><p> </p><p> </p><p> </p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.</p><p> </p><p> </p><p> </p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.</p><p> </p>
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2014-10-29T17:12:28.3318918Zmore like thismore than 2014-10-29T17:12:28.3318918Z
star this property question first ministerially corrected
less than 2014-11-13T10:22:56.0372213Zmore like thismore than 2014-11-13T10:22:56.0372213Z
star this property answering member
4020
star this property label Biography information for George Freeman more like this
star this property previous answer version
25123
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property answering member
4020
star this property label Biography information for George Freeman more like this
star this property tabling member
4026
unstar this property label Biography information for Liz Kendall more like this
100630
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department for Transport more like this
unstar this property answering dept id 27 more like this
star this property answering dept short name Transport more like this
star this property answering dept sort name Transport more like this
star this property hansard heading Railways: North West more like this
star this property house id 2 more like this
star this property legislature
25277
unstar this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government what assessment they have made of the case for improving inter-regional rail links in the North West of England, particularly between East Lancashire and Greater Manchester. more like this
star this property tabling member printed
Baroness Massey of Darwen more like this
unstar this property uin HL2361 more like this
star this property answer
answer
unstar this property is ministerial correction true more like this
star this property date of answer less than 2014-10-30more like thismore than 2014-10-30
unstar this property answer text <p>The case for improving inter-regional rail links in the North West of England has been assessed in a number of studies including the Northern Hub and Network Rail’s Lancashire and Cumbria and North-West Route Utilisation strategies. The case will be further addressed in respect of Network Rail’s Control Period 6 (2019-20<ins class="ministerial">2</ins><del class="ministerial">1</del>4) and beyond through the Northern Route Study as part of Network Rail’s Long Term Planning Process to inform decisions on the Government’s Rail Investment Strategy for Control Period 6.</p> more like this
star this property answering member printed Baroness Kramer more like this
star this property question first answered
less than 2014-10-30T12:12:57.52Zmore like thismore than 2014-10-30T12:12:57.52Z
star this property question first ministerially corrected
less than 2014-11-05T12:17:05.0180707Zmore like thismore than 2014-11-05T12:17:05.0180707Z
star this property answering member
1557
star this property label Biography information for Baroness Kramer more like this
star this property previous answer version
25208
star this property answering member printed Baroness Kramer more like this
star this property answering member
1557
star this property label Biography information for Baroness Kramer more like this
star this property tabling member
2489
unstar this property label Biography information for Baroness Massey of Darwen more like this
100603
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Ministry of Justice more like this
unstar this property answering dept id 54 more like this
star this property answering dept short name Justice more like this
star this property answering dept sort name Justice more like this
star this property hansard heading Prisoners: Suicide more like this
star this property house id 2 more like this
star this property legislature
25277
unstar this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government what steps they are taking to reduce the number of suicides in HM prisons. more like this
star this property tabling member printed
Lord Clinton-Davis more like this
unstar this property uin HL2334 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2014-11-06more like thismore than 2014-11-06
unstar this property answer text <p /> <p>Every death in custody is a tragedy, and the Government is committed to reducing the number of self-inflicted deaths in prisons. All prisons are required to have procedures in place to identify, manage and support people who are at risk of harm to themselves. These procedures include the Assessment, Care in Custody and Teamwork (ACCT) process, which is a prisoner-centred, flexible care planning system for prisoners identified as at risk of suicide or self-harm. Prisons are also required to ensure that they have procedures in place to learn from deaths in custody to prevent future occurrences.</p><p> </p><p>We are working hard to understand the reasons for the recent rise in the number of self-inflicted deaths, but there is no simple explanation. Additional resources and support are being provided for safer custody work in prisons, and in particular to improve the consistency of the ACCT system. The National Offender Management Service has also put in place additional staff at regional level to support staff in prisons and to share good practice, and created a dedicated learning and knowledge management team at headquarters which is providing further support for safer custody work.</p><p> </p><p>Data on deaths in custody is published quarterly in the Safety in Custody Statistics Bulletin, available at <a href="http://www.gov.uk/government/publications/safety-in-custody-statistics" target="_blank">www.gov.uk/government/publications/safety-in-custody-statistics</a>.</p>
star this property answering member printed Lord Faulks more like this
star this property question first answered
less than 2014-11-06T17:46:36.7179963Zmore like thismore than 2014-11-06T17:46:36.7179963Z
star this property answering member
4183
star this property label Biography information for Lord Faulks more like this
star this property tabling member
1116
unstar this property label Biography information for Lord Clinton-Davis more like this
100604
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department for Business, Innovation and Skills more like this
unstar this property answering dept id 26 more like this
star this property answering dept short name Business, Innovation and Skills more like this
star this property answering dept sort name Business, Innovation and Skills more like this
star this property hansard heading Apprentices more like this
star this property house id 2 more like this
star this property legislature
25277
unstar this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government how many (1) 16 year-olds, (2) 17 year-olds, and (3) 18 year-olds started apprenticeships in the academic years 2012–13 and 2013–14 in England. more like this
star this property tabling member printed
Lord Smith of Clifton more like this
unstar this property uin HL2335 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2014-10-29more like thismore than 2014-10-29
unstar this property answer text <p>Table 1 shows the number of apprenticeship starts for 16, 17 and 18 year olds in 2012/13 and provisional full year apprenticeship starts for the same ages in 2013/14. Provisional data are subject to change and should not be directly compared with data from earlier academic years.</p><p> </p><p> </p><p> </p><p> </p><p> </p><p><strong>Table 1: Apprenticeship starts by age (2012/13 and 2013/14 provisional full year)</strong></p><p> </p><table><tbody><tr><td><p><strong> </strong></p></td><td><p><strong>2012/13</strong></p></td><td><p><strong>2013/14</strong></p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p>Full year</p></td></tr><tr><td><p>Age</p></td><td><p>Full year</p></td><td><p>(provisional)</p></td></tr><tr><td><p>16</p></td><td><p>25,080</p></td><td><p>25,170</p></td></tr><tr><td><p>17</p></td><td><p>35,810</p></td><td><p>38,320</p></td></tr><tr><td><p>18</p></td><td><p>53,430</p></td><td><p>54,140</p></td></tr></tbody></table><p> </p><p>Notes</p><p> </p><p>1) Volumes are rounded to the nearest 10.</p><p> </p><p>2) Age is calculated based on age at start of the programme rather than based on 31 August.</p><p> </p><p>3) Provisional data are subject to change and should not be directly compared with data from earlier academic years.</p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p>
star this property answering member printed Baroness Neville-Rolfe more like this
star this property question first answered
less than 2014-10-29T17:05:23.7910885Zmore like thismore than 2014-10-29T17:05:23.7910885Z
star this property answering member
4284
star this property label Biography information for Baroness Neville-Rolfe more like this
star this property tabling member
3144
unstar this property label Biography information for Lord Smith of Clifton more like this
100605
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Foreign and Commonwealth Office more like this
unstar this property answering dept id 16 more like this
star this property answering dept short name Foreign and Commonwealth Office more like this
star this property answering dept sort name Foreign and Commonwealth Office more like this
star this property hansard heading Council of Europe more like this
star this property house id 2 more like this
star this property legislature
25277
unstar this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government whether they will be represented at the forthcoming Council of Europe conference in Baku, Azerbaijan; and what representations they will make regarding the implementation of recent European Court of Human Rights decisions concerning Azerbaijan. more like this
star this property tabling member printed
Lord Hylton more like this
unstar this property uin HL2336 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2014-11-03more like thismore than 2014-11-03
unstar this property answer text <p>The British Government takes all opportunities to raise its concerns about the lack of fundamental freedoms in Azerbaijan, including the implementation of judgments by the European Court of Human Rights, and does so at a range of levels on a regular basis. The UK will be represented at official level at Azerbaijan's forthcoming closing Council of Europe conference in Baku.</p> more like this
star this property answering member printed Baroness Anelay of St Johns more like this
star this property question first answered
less than 2014-11-03T15:18:50.3344515Zmore like thismore than 2014-11-03T15:18:50.3344515Z
star this property answering member
3474
star this property label Biography information for Baroness Anelay of St Johns more like this
star this property tabling member
2018
unstar this property label Biography information for Lord Hylton more like this
100606
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Foreign and Commonwealth Office more like this
unstar this property answering dept id 16 more like this
star this property answering dept short name Foreign and Commonwealth Office more like this
star this property answering dept sort name Foreign and Commonwealth Office more like this
star this property hansard heading Azerbaijan more like this
star this property house id 2 more like this
star this property legislature
25277
unstar this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government whether they plan to send observers to the imminent trials in Azerbaijan of (1) Mr Arif and Ms Leyla Yunus of the Peace and Democracy Institute, (2) Mr Intigam Aliyev, and (3) Mr Rasul Jafarov; and whether they will propose that their trials are fully covered by European Union diplomats. more like this
star this property tabling member printed
Lord Hylton more like this
unstar this property uin HL2337 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2014-11-05more like thismore than 2014-11-05
unstar this property answer text <p>The British Government has publicly expressed its concern surrounding the arrests of Mr Arif and Ms Leyla Yunus and Mr Rasul Jafarav amongst others, and supports the EU statement of 14 August 2014 regarding the recent deterioration of the human rights situation in Azerbaijan. As has been the case in recent high profile trials, the British Government expects to make representation in coordination with its EU partners.</p> more like this
star this property answering member printed Baroness Anelay of St Johns more like this
star this property question first answered
less than 2014-11-05T15:49:52.6019191Zmore like thismore than 2014-11-05T15:49:52.6019191Z
star this property answering member
3474
star this property label Biography information for Baroness Anelay of St Johns more like this
star this property tabling member
2018
unstar this property label Biography information for Lord Hylton more like this
100607
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Ministry of Defence more like this
unstar this property answering dept id 11 more like this
star this property answering dept short name Defence more like this
star this property answering dept sort name Defence more like this
star this property hansard heading RFA Argus more like this
star this property house id 2 more like this
star this property legislature
25277
unstar this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government whether they plan to expand the instructions given to RFA Argus so as to enable its medical facilities to assist all urgent cases from Sierra Leone or nearby states. more like this
star this property tabling member printed
Lord Hylton more like this
unstar this property uin HL2338 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2014-11-07more like thismore than 2014-11-07
unstar this property answer text <p>RFA ARGUS is deployed to support the Government's efforts in Sierra Leone. Her primary role is to act as a logistics lift capability and aviation platform, with three embarked Merlin helicopters. RFA ARGUS does, however, have a limited medical capability on board to treat disease and non-battle injury. Treatment of those suffering from Ebola is carried out at separate facilities ashore, the first of which opened in Kerry Town on 5 November and will have the capacity to treat 80 local patients. Also at Kerry Town the UK military is currently manning a 12 bed treatment unit for national and international healthcare workers.</p> more like this
star this property answering member printed Lord Astor of Hever more like this
star this property question first answered
less than 2014-11-07T14:57:55.61541Zmore like thismore than 2014-11-07T14:57:55.61541Z
star this property answering member
3428
star this property label Biography information for Lord Astor of Hever more like this
star this property tabling member
2018
unstar this property label Biography information for Lord Hylton more like this